Clearside Biomedical股价下跌,公司宣布探索战略选择方案

英为财情
Jul 17, 2025

Investing.com -- Clearside Biomedical, Inc. (NASDAQ:CLSD)周四股价下跌0.7%,此前该公司宣布计划探索战略选择方案,以推进其专有的脉络膜上腔递送平台和眼科产品管线。 这家生物制药公司表示,已聘请Piper Sandler支持战略评估过程,可能包括资产的出售、许可、变现或剥离,以及潜在的合作、伙伴关系、合并或收购。 作为该过程的一部分,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10